These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28819437)

  • 1. Impact of Detection Method and Accompanying Ductal Carcinoma in Situ on Prognosis of T1a,bN0 Breast Cancer.
    Shen SC; Ueng SH; Yang CK; Yu CC; Lo YF; Chang HK; Lin YC; Chen SC
    J Cancer; 2017; 8(12):2328-2335. PubMed ID: 28819437
    [No Abstract]   [Full Text] [Related]  

  • 2. Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer.
    Durak MG; Gonzalez-Angulo AM; Hanrahan EO; Broglio KR; Valero V; Hortobagyi GN; Hunt KK; Sahin AA
    Breast J; 2011; 17(5):462-9. PubMed ID: 21726347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
    Fang Y; Wu J; Wang W; Fei X; Zong Y; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    Oncotarget; 2016 Sep; 7(39):64182-64190. PubMed ID: 27577080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.
    Wu SG; Zhang WW; Sun JY; He ZY
    Cancer Manag Res; 2018; 10():527-534. PubMed ID: 29593431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.
    Hanrahan EO; Valero V; Gonzalez-Angulo AM; Hortobagyi GN
    J Clin Oncol; 2006 May; 24(13):2113-22. PubMed ID: 16648513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers.
    Sänger N; Engels K; Graf A; Ruckhäberle E; Effenberger KE; Fehm T; Holtrich U; Becker S; Karn T
    Geburtshilfe Frauenheilkd; 2014 Nov; 74(11):1016-1022. PubMed ID: 25484376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
    Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
    Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
    Théberge I; Vandal N; Guertin MH; Perron L
    Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?
    Chagpar AB; McMasters KM; Sahoo S; Edwards MJ
    Surgery; 2009 Oct; 146(4):561-7; discussion 567-8. PubMed ID: 19789013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
    Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
    Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor biology, clinicopathological characteristics and prognosis of screen detected T1 invasive non-palpable breast cancer in asymptomatic Chinese women (2001-2014).
    Pan B; Yao R; Zhou YD; Zhu QL; Shi J; Xu QQ; Wang CJ; You SS; Mao F; Lin Y; Shen SJ; Liang ZY; Jiang YX; Sun Q
    Oncotarget; 2017 Apr; 8(16):26221-26230. PubMed ID: 28412736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
    Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
    Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinic-Pathological Features of Breast Ductal Carcinoma
    Zheng J; Zhou T; Li F; Shi J; Zhang L
    Cancer Invest; 2020 Feb; 38(2):113-121. PubMed ID: 31939679
    [No Abstract]   [Full Text] [Related]  

  • 20. Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold?
    Kelly CM; Pritchard KI; Trudeau M; Andreopoulou E; Hess K; Pusztai L
    Ann Oncol; 2011 Nov; 22(11):2387-2393. PubMed ID: 21406473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.